INTS12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.522800E-01
Normal-vs-Stage2
2.569800E-01
Normal-vs-Stage3
2.521200E-01
Normal-vs-Stage4
8.738600E-01
Stage1-vs-Stage2
5.387200E-01
Stage1-vs-Stage3
3.248800E-01
Stage1-vs-Stage4
3.823600E-01
Stage2-vs-Stage3
5.483400E-01
Stage2-vs-Stage4
1.185420E-01
Stage3-vs-Stage4
2.526200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.051400E-01
Normal-vs-AfricanAmerican
3.166000E-01
Normal-vs-Asian
3.738200E-01
Caucasian-vs-AfricanAmerican
8.801400E-01
Caucasian-vs-Asian
9.827800E-01
AfricanAmerican-vs-Asian
9.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.915210E-01
Normal-vs-Female
4.729000E-01
Male-vs-Female
2.872000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.827200E-01
Normal-vs-Age(41-60Yrs)
5.572200E-01
Normal-vs-Age(61-80Yrs)
2.287200E-01
Normal-vs-Age(81-100Yrs)
8.117700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.559000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.913000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.988390E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.997100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.210420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.802600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.650750E-01
Normal-vs-Daily Drinker
1.243400E-01
Normal-vs-Weekly Drinker
2.661000E-01
Normal-vs-Occasional Drinker
5.885000E-01
Normal-vs-Social Drinker
1.103390E-01
Non Drinker-vs-Daily Drinker
8.832800E-01
Non Drinker-vs-Weekly Drinker
6.692000E-01
Non Drinker-vs-Occasional Drinker
1.475000E-01
Non Drinker-vs-Social Drinker
5.558400E-01
Daily Drinker-vs-Weekly Drinker
7.455400E-01
Daily Drinker-vs-Occasional Drinker
1.800410E-01
Daily Drinker-vs-Social Drinker
6.142000E-01
Weekly Drinker-vs-Occasional Drinker
4.040200E-01
Weekly Drinker-vs-Social Drinker
9.262000E-01
Occasional Drinker-vs-Social Drinker
3.531600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.118200E-01
Normal-vs-Grade 2
5.787000E-01
Normal-vs-Grade 3
5.835400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.656840E-01
Grade 1-vs-Grade 3
1.974980E-01
Grade 1-vs-Grade 4
3.118200E-01
Grade 2-vs-Grade 3
9.118000E-01
Grade 2-vs-Grade 4
5.787000E-01
Grade 3-vs-Grade 4
5.835400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.542000E-01
Normal-vs-NonDiabetic
3.431800E-01
Diabetic-vs-NonDiabetic
9.527800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.416600E-01
Normal-vs-NoPancreatitis
2.589000E-01
Pancreatitis-vs-NoPancreatitis
2.485000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.998400E-01
Normal-vs-N1
2.709200E-01
N0-vs-N1
7.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.870400E-01
Normal-vs-TP53-NonMutant
6.285000E-01
TP53-Mutant-vs-TP53-NonMutant
3.369400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
